; or (cc) drugs, biological products, devices or technologies intended to enhance the use or effect of a drug, biological product, or device described in item (aa) or (bb); and (ii) personal protective equipment, including protective equipment for eyes, face, head, and extremities, protective clothing, respiratory devices, and protective shields and barriers, used to protect people from COVID–19 infection. (B) Consultation In developing the list described in subparagraph (A), the Secretary shall consult with the Administrator of the Federal Emergency Management Administration and the Secretary of Defense to ensure that, in instances where the President has enacted the Defense Production Act to produce applicable COVID–19 products, the Office does not replicate or overproduce products being developed under the Act. (3) Native health program The term Native health program shall include— (A) a program provided through the Indian Health Service; (B) any health program operated by— (i) an Indian tribe, or Tribal organization, as such terms are defined in section 4 of the Indian Self-Determination and Education Assistance Act; (ii) an inter-tribal consortium, as defined in section 501(a) of the Indian Self-Determination and Education Assistance Act; or (iii) an urban Indian organization, as defined in section 4 of the Indian Health Care Improvement Act; and (C) any health program provided through a Native Hawaiian health care system, as defined in section 12 of the Native Hawaiian Health Care Improvement Act. (4) Domestic health care provider The term domestic health care provider shall include the direct support professional, home health, and personal care attendant workforce. (g) Authorization of appropriations There are authorized to be appropriated such sums as may be necessary to carry out this section. .